- FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer2009 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia2017 | Third Faculty of Medicine
- Quantitative Molecular Monitoring of Tumor Cells in Chronic Lymphocytic Leukemia Treated with combined chemo/immunotherapyPublication without faculty affiliation
- Immunocomplexes of IL-2 and Anti-IL-2 mAB as novel promising tool for cancer immunotherapy or combined chemo/immunotherapyPublication without faculty affiliation
- The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia2017 | Third Faculty of Medicine
- Quantitation of minimal residual disease in patients with chronic lymphocytic leukemia using locked nucleic acid-modified, fluorescently labeled hybridization probes and real-time PCR technology2007 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Quantitation of minimal residual disease in patients with chronic lymphocytic leukemia using locked nucleic acid-modified, fluorescently labeled hybridization probes and real-time PCR technology2007 | Second Faculty of Medicine
- Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations2015 | Faculty of Medicine in Pilsen
- Imunogenic cell death and it ´s application in immunotherapy protocolsPublication without faculty affiliation
- Trial watch: Dendritic cell (DC)-based immunotherapy for cancer2022 | Second Faculty of Medicine
- Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group2021 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse2022 | First Faculty of Medicine, Third Faculty of Medicine